Heart failure (HF) is still a global public health issue, despite the enormous progress made
in its diagnosis and treatment. More often than not, acute or chronic decompensated HF …

Background Chronic heart failure (HF) is a relevant and growing public health problem.
Although the prognosis has recently improved, it remains a lethal disease, with a mortality …

The management of heart failure patients (diagnosis, treatment monitoring, assessment of
prognosis) crucially depends on the accuracy of the tools used for patient evaluation. While …

BACKGROUND: It was the aim of this study to compare the prognostic impact of
echocardiography and brain natriuretic peptide and its N-terminal fragment (NT-proBNP) in …

Heart failure (HF) patients present frequently comorbidities and the diagnosis of HF in this
setting is a challenge. The symptoms and signs of HF may be atypical and can be simulated …

Natriuretic peptides (NPs) are entered in current guidelines for heart failure (HF) diagnosis
and management because of their high specificity and sensibility in screening patients with …

Heart failure (HF) is a major health burden worldwide. Among individuals aged 55 years and
older, almost 1 in 3 will develop HF during their remaining life span, with only about 50 …

Chronic heart failure (HF) is an important public health problem and is associated with high
morbidity, high mortality, and considerable healthcare costs. More than 90% of …

Aims Previous evaluations of natriuretic peptide (NP) levels in patients with acute dyspnoea
presenting to the emergency department (ED) have selected only a minority of patients for …

Heart failure (HF) is a threat to public health. Heterogeneities in aetiology and phenotype
complicate the diagnosis and management of HF. This is especially true when considering …